Alnylam Pharmace. buy JPMorgan Chase & Co.
Start price
16.07.25
/
50%
€277.50
Target price
16.07.26
€299.70
Performance (%)
-11.71%
End price
17.07.26
€245.00
Summary
This prediction ended on 17.07.26 with a price of €245.00. The prediction for Alnylam Pharmace. disappointed with a performance of -11.71%. JPMorgan_Chase___Co_ has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | 0.895% | 0.895% | -48.866% |
| iShares Core DAX® | 0.184% | 5.072% | 8.979% |
| iShares Nasdaq 100 | -0.770% | -2.079% | 26.437% |
| iShares Nikkei 225® | 0.733% | -3.346% | 47.887% |
| iShares S&P 500 | -0.166% | 0.904% | 22.974% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Alnylam Pharmace. diskutieren
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its price target raised by analysts at JPMorgan Chase & Co. from $338.00 to $348.00. They now have an "overweight" rating on the stock.
Ratings data for ALNY provided by MarketBeat
In the thread Trading Alnylam Pharmace.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€406.80
13.10.25
13.10.25
€407.06
13.10.26
13.10.26
-52.91%
13:52
13:52
Stopped prediction by JPMorgan_Chase___Co_ for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€234.00
22.07.26
22.07.26
€350.68
22.07.27
22.07.27
-18.14%
13:52
13:52
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€264.00
12.06.25
12.06.25
€296.26
12.06.26
12.06.26
-7.54%
13.06.26
13.06.26
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€270.10
24.03.25
24.03.25
€302.97
24.03.26
24.03.26
-3.00%
25.03.26
25.03.26